Respiratory Disease Testing Market, By Product (Imaging tests, Blood gas test, and Respiratory measurement devices), By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
REPORT HIGHLIGHT
Respiratory Disease Testing Market size was valued at USD 6,590.43 Million in 2024, expanding at a CAGR of 2.99% from 2025 to 2032.
Respiratory disease testing is a diagnostic tool used to detect, assess, and monitor conditions that impact the respiratory system, including the lungs, airways, and other structures involved in breathing. These tests are essential for identifying a range of conditions, such as asthma, chronic obstructive pulmonary disease (COPD), pneumonia, tuberculosis, lung cancer, and infections like the COVID-19 virus.
Respiratory Disease Testing Market- Market Dynamics
Ø Growing prevalence of infectious respiratory diseases and rising digital integration are expected to propel market demand
The respiratory disease testing market is poised for significant growth, driven by a combination of factors, including the increasing incidence of respiratory disorders and ongoing advancements in technology. Chronic respiratory conditions, such as asthma, chronic obstructive pulmonary disease (COPD), and interstitial lung diseases, are becoming more prevalent globally. According to the World Health Organization (WHO), COPD is a leading cause of death worldwide, and asthma affects hundreds of millions of people. Additionally, the widespread adoption of rapid testing methods like RT-PCR, which gained widespread recognition during the COVID-19 pandemic, has led to expanded diagnostic lab capacities.
Technological innovations, including molecular diagnostics, polymerase chain reaction (PCR) tests, and next-generation sequencing (NGS), have significantly enhanced the accuracy and reliability of respiratory disease detection. The introduction of portable and rapid diagnostic tools has made testing more accessible, particularly in remote and underserved areas. These advancements are especially valuable in emergency situations where quick results are crucial. The integration of artificial intelligence (AI) and machine learning (ML) into diagnostic workflows is further improving test speed and precision. AI-powered technologies are also being utilized to enhance the interpretation of imaging tests, such as chest X-rays and CT scans. While the high cost of advanced diagnostic tools and disparities in healthcare access remain challenges, innovations such as telemedicine and affordable testing solutions are helping to overcome these barriers. These developments are expected to further accelerate market growth, making respiratory disease testing more accessible, efficient, and effective worldwide.
Respiratory Disease Testing Market- Segmentation Analysis:
The Global Respiratory Disease Testing Market is segmented on the basis of Product, Application, End User, and Region.
The market is segmented into four categories based on product: imaging tests, blood gas tests, respiratory measurement devices, and others. Among these, the imaging tests segment dominates the market. The increasing adoption of advanced imaging technologies, such as X-ray machines, CT scanners, and 3D imaging platforms, is driving growth in this segment. These devices play a critical role in the diagnosis and monitoring of respiratory diseases, providing high-resolution images that enable early detection and better treatment outcomes. According to the U.S. Food and Drug Administration (FDA), medical imaging is a cornerstone of modern healthcare, with the market for diagnostic imaging equipment projected to grow significantly. The continuous advancements in imaging technologies, such as the development of more accurate and efficient imaging systems, are further propelling the demand for imaging tests, particularly in the detection of respiratory conditions like lung cancer and COPD.
The market is divided into five categories based on application: lung cancer, tuberculosis, asthma, chronic obstructive pulmonary disease (COPD), and others. The tuberculosis segment is expected to hold the largest market share due to the high prevalence of tuberculosis, particularly in low- and middle-income countries. According to the World Health Organization (WHO), tuberculosis remains one of the top 10 causes of death worldwide, with an estimated 10 million people falling ill with the disease each year. Early and accurate diagnosis through advanced diagnostic tests is crucial for controlling the spread of tuberculosis. However, the lung cancer segment is expected to grow at the fastest rate during the forecast period. This growth is driven by the increasing focus on preventive diagnosis and the rising incidence of lung cancer globally. The American Cancer Society reports that lung cancer is the leading cause of cancer-related deaths in both men and women in the U.S., and early detection through imaging and diagnostic tests is critical for improving survival rates.
The market is also divided into three categories based on end user: hospitals, clinical laboratories, and others. The hospitals segment holds the largest share in the end-user category. Hospitals are the primary setting for diagnosing and treating patients with respiratory diseases, particularly given the increasing prevalence of conditions such as asthma, COPD, and lung cancer. The Centers for Disease Control and Prevention (CDC) reports that approximately 16 million Americans suffer from chronic obstructive pulmonary disease (COPD), making it one of the most common respiratory conditions in the U.S. The growing need for advanced diagnostic devices and the rising number of patients with respiratory illnesses are contributing to the growing demand for hospital-based diagnostic services. Furthermore, hospitals continue to invest in cutting-edge diagnostic technologies, enhancing their ability to provide timely and accurate diagnoses, which further strengthens their dominance in the market.
Respiratory Disease Testing Market- Geographical Insights
The global Respiratory Disease Testing market is spread across various regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America holds a substantial share of the market, driven by its advanced healthcare infrastructure, widespread use of cutting-edge diagnostic technologies, and significant investments in research and development. As reported by the American Lung Association, around 16 million Americans were diagnosed with chronic obstructive pulmonary disease (COPD) in 2023, further emphasizing the region\'s demand for respiratory disease testing.
The Asia-Pacific region is projected to experience the highest growth in the respiratory disease testing market, fueled by a large patient base, ongoing improvements in healthcare systems, and increased healthcare investments. Countries such as China and India face high rates of respiratory conditions like tuberculosis (TB), COPD, and other respiratory infections, largely due to factors like air pollution and smoking. As healthcare infrastructure continues to improve, the demand for effective respiratory disease testing solutions in these regions is expected to rise significantly.
Respiratory Disease Testing Market- Competitive Landscape:
The respiratory disease testing market is highly competitive, with a mix of global, regional, and emerging players offering a variety of diagnostic solutions. The competition is driven by the growing demand for advanced, accurate, and rapid testing methods. In emerging economies, startups and smaller companies are making significant strides by introducing portable and affordable solutions. These innovations are helping to meet the rising demand for accessible diagnostics. Additionally, market players are focusing on microbiology and molecular diagnostics to address respiratory infections like tuberculosis and pneumonia. Companies are heavily investing in research and development to create cutting-edge diagnostic solutions that cater to the evolving needs of healthcare providers and patients.
Recent Developments:
v In October 2024, Quest Diagnostics launched a new test for H5N1 bird flu, expanding its diagnostic portfolio to address emerging infectious diseases.
v In October 2024, Oxford Nanopore partnered with NHS England to accelerate the screening of new pathogens, enhancing their capacity for rapid detection and monitoring.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL RESPIRATORY DISEASE TESTING MARKET KEY PLAYERS
Ø Thermo Fisher Scientific Inc.
Ø Abbott Laboratories
Ø F. Hoffmann-La Roche AG
Ø Siemens Healthineers
Ø Becton, Dickinson and Company (BD)
Ø bioMérieux SA
Ø Quest Diagnostics Incorporated
Ø Danaher Corporation
Ø PerkinElmer Inc.
Ø MGC Diagnostics Corporation
Ø Oxford Nanopore
Ø Agilent Technologies, Inc.
Ø Vyaire Medical, Inc.
Ø Philips Healthcare
Ø GE HealthCare Technologies Inc.
Ø Others
GLOBAL RESPIRATORY DISEASE TESTING MARKET, BY PRODUCT- MARKET ANALYSIS, 2019-2032
Ø Imaging tests
Ø Blood gas test
Ø Respiratory measurement devices
Ø Others
GLOBAL RESPIRATORY DISEASE TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032
Ø Lung cancer
Ø Tuberculosis
Ø Asthma
Ø Chronic obstructive pulmonary disease (COPD)
Ø Others
GLOBAL RESPIRATORY DISEASE TESTING MARKET, BY END USER- MARKET ANALYSIS, 2019-2032
Ø Hospitals
Ø Clinical Laboratories
Ø Others
GLOBAL RESPIRATORY DISEASE TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019-2032
Ø North America
o The U.S.
o Canada
Ø Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Ø Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Ø Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
Ø The Middle East and Africa
o Saudi Arabia
o UAE
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Respiratory Disease Testing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Respiratory Disease Testing Market Snippet by Product
2.1.2. Respiratory Disease Testing Market Snippet by Application
2.1.3. Respiratory Disease Testing Market Snippet by End User
2.1.4. Respiratory Disease Testing Market Snippet by Country
2.1.5. Respiratory Disease Testing Market Snippet by Region
2.2. Competitive Insights
3. Respiratory Disease Testing Key Market Trends
3.1. Respiratory Disease Testing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Respiratory Disease Testing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Respiratory Disease Testing Market Opportunities
3.4. Respiratory Disease Testing Market Future Trends
4. Respiratory Disease Testing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Respiratory Disease Testing Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Respiratory Disease Testing Market Landscape
6.1. Respiratory Disease Testing Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Respiratory Disease Testing Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
7.1.2. Imaging tests
7.1.3. Blood gas test
7.1.4. Respiratory measurement devices
7.1.5. Others
8. Respiratory Disease Testing Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
8.1.2. Lung cancer
8.1.3. Tuberculosis
8.1.4. Asthma
8.1.5. Chronic obstructive pulmonary disease (COPD)
8.1.6. Others
9. Respiratory Disease Testing Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
9.1.2. Hospitals
9.1.3. Clinical Laboratories
9.1.4. Others
10. Respiratory Disease Testing Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Respiratory Disease Testing Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Respiratory Disease Testing Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Respiratory Disease Testing Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Respiratory Disease Testing Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Respiratory Disease Testing Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Respiratory Disease Testing Industry
11.1. Competitive Dashboard
11.1.1. Competitive Benchmarking
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Thermo Fisher Scientific Inc.
11.2.2. Abbott Laboratories
11.2.3. F. Hoffmann-La Roche AG
11.2.4. Siemens Healthineers
11.2.5. Becton, Dickinson and Company (BD)
11.2.6. bioMérieux SA
11.2.7. Quest Diagnostics Incorporated
11.2.8. Danaher Corporation
11.2.9. PerkinElmer Inc.
11.2.10. MGC Diagnostics Corporation
11.2.11. Oxford Nanopore
11.2.12. Agilent Technologies, Inc.
11.2.13. Vyaire Medical, Inc.
11.2.14. Philips Healthcare
11.2.15. GE HealthCare Technologies In
11.2.16. Others
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
